ArticleJournal of translational medicine2025
Correction: Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax.
Ilenia Valentino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.